Hemab is a clinical-stage biotech company developing prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders.
Sign up today and learn more about Hemab Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Hemab Stock
CTO & Co-Founder
Johan H. Faber
Chief Executive Officer
Chief Financial Officer